Dmitry Balyasny’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.5M Buy
+616,404
New +$42.8M 0.06% 387
2025
Q3
– Sell
-138,019
Closed -$5.59M – 3457
2025
Q2
$5.59M Buy
138,019
+78,345
+131% +$3.53M 0.01% 1234
2025
Q1
$3.07M Buy
+59,674
New +$2.95M 0.01% 1489

Other funds holding TARS

Dmitry Balyasny's TARS Position: Q3 2026 in Review

Dmitry Balyasny opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2026: 616,404 shares worth $48.5M. The stake represents 0.06% of the portfolio and ranks #387 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in TARS as recently as Q2 2025.

Dmitry Balyasny first reported a position in TARS in Q1 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Dmitry Balyasny held 616,404 shares of Tarsus Pharmaceuticals worth $48.5M as of Q3 2026.
  • Tarsus Pharmaceuticals was a new Dmitry Balyasny position in Q3 2026.
  • Tarsus Pharmaceuticals made up 0.06% of Dmitry Balyasny's portfolio in Q3 2026, its #387 holding.
  • Dmitry Balyasny first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.